Pharma Mar, S.A. (BME:PHM)
Spain
· Delayed Price · Currency is EUR 79.55
-4.40 (-5.24%)
Mar 3, 2026, 2:23 PM CET
Pharma Mar Market Cap
Pharma Mar has a market cap or net worth of €1.45 billion as of March 3, 2026. Its market cap has decreased by -15.61% in one year.
Market Cap
1.45B
Enterprise Value
1.35B
Revenue
179.28M
Ranking
n/a
PE Ratio
43.16
Stock Price
€79.55
Market Cap Chart
Since November 2, 2015, Pharma Mar's market cap has decreased from 1.80B to 1.45B, a decrease of -19.46%. That is a compound annual growth rate of -2.07%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Grifols | 6.47B |
| Laboratorios Farmaceuticos Rovi | 4.33B |
| Almirall | 2.77B |
| Faes Farma | 1.62B |
| Clínica Baviera | 835.83M |
| Oryzon Genomics | 247.60M |
| Prim, S.A. | 232.27M |
| Atrys Health | 224.59M |